Why Has Progyny Stock Rallied 90% Since Its Listing?

Progyny (NASDAQ: PGNY), is a benefits management company that specializes in fertility and family building benefits solutions. The company’s stock is up 90% since its listing in late October, currently trading at over $30 per share. The IPO was priced at $13. The rally is driven by strong demand for the stock, given that fertility coverage is expanding among employers. Moreover, the company has been recording robust revenue growth (over 110% CAGR over the last 2 years) and is expected to post an operating profit this year. However, it’s possible that the company could face some selling pressure next year, as its IPO lock-up expires in April 2020.

We ‘step back’ from these recent swings to review Progyny’s performance over the last few years, as a context for what might come next. Our Interactive dashboard, Why Progeny Stock Is Up 90% Since Its IPO reviews the near term reasons and the big picture.

The context for the last few years:

A closer look At Progyny’s Total Revenues over the last few years and the outlook 

Total Revenues for Progyny increased from $48.6 Mil in 2017 to $105 Mil in 2018; an increase of 116%. We expect Total Revenues growth to be 213% in 2019.

A closer look At Progyny’s Total Expenses over the last few years and the outlook

Total Expense for Progyny increased from $61 Mil 2017 to $112 Mil in 2018; an increase of 85%. We expect Total Expense growth to be 194% in 2019.

How has  Progyny’s  EBT trended?

EBT for the company improved from -12.5 Mil in 2017 to -$6.9 Mil in 2018. We expect EBT to rise to $0.2 Mil in 2019.

How has Progyny’s Net Income and EPS trended?

For more details on Progyny’s net income and EPS, view our interactive dashboard analysis.

What’s behind Trefis? See How it’s Powering New Collaboration and What-Ifs

For CFOs and Finance Teams | Product, R&D, and Marketing Teams

More Trefis Data

Like our charts? Explore example interactive dashboards and create your own.